+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cost benefit analysis of tetanus prophylaxis by a mathematical model



Cost benefit analysis of tetanus prophylaxis by a mathematical model



Epidemiology & Infection 102(3): 473-484



A mathematical model has been developed which allows estimation of the epidemiological and economic effects of different tetanus vaccination strategies. The model was used to simulate the epidemiology of tetanus in Italy from 1955 to 1982, and then applied to a district of Tuscany by utilizing data obtained from a seroepidemiological survey carried out in the same area. For this district we simulated vaccination programmes designed to reach, within 1 or 10 years, coverages of 60 or 90% of the population aged over 10 years who had not been exposed to the neonatal vaccination programme. The most effective strategy, from both the epidemiological and economic point of view, seems to be 90% coverage reached in 1 year's time. Benefits would be increased by improving the reliability of vaccinal anamnesis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007165526

Download citation: RISBibTeXText

PMID: 2500356

DOI: 10.2307/3863694


Related references

Mathematical model for cost benefit analysis of colorectal cancer screening. Rozen, P , C B Reich And S J Winawer (Ed ) Frontiers Of Gastrointestinal Research, Vol 18 Large Bowel Cancer: Policy, Prevention, Research And Treatment; 2nd International Conference on Gastrointestinal Cancer, Jerusalem, Israel, 1989 Viii+301p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 181-199, 1991

A mathematical model for cost-benefit analysis in the use of amphotericin B with Blom-Singer prostheses. Algaba, J International Congress Series; Surgery and prosthetic voice restoration after total and subtotal laryngectomy 371-376, 1996

A mathematical analysis of leaf longevity of trees under seasonally varying temperatures, based on a cost-benefit model. Evolutionary Ecology Research 8(4): 605-615, 2006

Economic evaluation of diphtheria, tetanus, and acellular pertussis vaccine in the United States A cost-benefit and cost-effectiveness model with visual basic application. Pediatric Research 45(4 PART 2): 122A, April, 1999

Cost-benefit analysis of the immunization of horses against tetanus. Nutzen Kosten Analyse der Schutzimpfung zur Bekampfung von Tetanus beim Pferd: 88, 1986

A cost-benefit analysis of RSV prophylaxis in high-risk infants. Annals of Pharmacotherapy 35(10): 1186-1193, October, 2001

Cost-benefit analysis of malaria prophylaxis with mefloquine in travelers to Kenya. Sozial- und Praventivmedizin 35(6): 213-219, 1990

Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery. Seminars in Thrombosis and Hemostasis 17 Suppl 3: 280-283, 1991

Septic arthritis following arthroscopy, with cost/benefit analysis of antibiotic prophylaxis. Arthroscopy 4(1): 10-14, 1988

Benefit-cost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy. JAMA 249(10): 1290-1294, 1983

Cost and benefit of perioperative antimicrobial prophylaxis: methods for economic analysis. Reviews of Infectious Diseases 13 Suppl 10: S879-S889, 1991

Cost-benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy. British Journal of Obstetrics and Gynaecology 95(11): 1170-1177, 1988

Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices. Asaio Journal 46(5): 587-589, 2000

Outcome of respiratory syncytial virus infection and a cost-benefit analysis of prophylaxis. Journal of Paediatrics and Child Health 36(5): 422-427, 2000